These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Design and synthesis of new 2-substituted-5-(2-benzylthiophenyl)-1,3,4-oxadiazoles as benzodiazepine receptor agonists. Zarghi A, Faizi M, Shafaghi B, Ahadian A, Khojastehpoor HR, Zanganeh V, Tabatabai SA, Shafiee A. Bioorg Med Chem Lett; 2005 Jun 15; 15(12):3126-9. PubMed ID: 15876530 [Abstract] [Full Text] [Related]
6. Novel N-(arylalkyl)indol-3-ylglyoxylylamides targeted as ligands of the benzodiazepine receptor: synthesis, biological evaluation, and molecular modeling analysis of the structure-activity relationships. Primofiore G, Settimo FD, Taliani S, Marini AM, Novellino E, Greco G, Lavecchia A, Besnard F, Trincavelli L, Costa B, Martini C. J Med Chem; 2001 Jul 05; 44(14):2286-97. PubMed ID: 11428922 [Abstract] [Full Text] [Related]
9. Modification of pyrazoloquinolinone affinity by GABA predicts efficacy at the benzodiazepine receptor. Brown CL, Martin IL. Eur J Pharmacol; 1984 Oct 30; 106(1):167-73. PubMed ID: 6099267 [Abstract] [Full Text] [Related]
17. Synthesis, structure-activity relationships, and molecular modeling studies of N-(indol-3-ylglyoxylyl)benzylamine derivatives acting at the benzodiazepine receptor. Da Settimo A, Primofiore G, Da Settimo F, Marini AM, Novellino E, Greco G, Martini C, Giannaccini G, Lucacchini A. J Med Chem; 1996 Dec 20; 39(26):5083-91. PubMed ID: 8978839 [Abstract] [Full Text] [Related]